A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms.
A University of Oxford study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, outlines a new type of blood test that can be used to detect a range of cancers and whether these cancers have spread (metastasised) in the body.
The study analysed samples from 300 patients with non-specific but concerning symptoms of cancer, such as fatigue and weight loss, who were recruited through the Oxfordshire Suspected CANcer (SCAN) pathway.
The researchers assessed whether the test could distinguish patients with a range of solid tumours from those without cancer. Their results show that cancer was correctly detected in 19 out of every 20 patients with cancer using this test. In those with cancer, metastatic disease was identified with an overall accuracy of 94%. These results make this the first technology to be able to determine the metastatic status of a cancer from a simple blood test, without prior knowledge of the primary cancer type.
This test shows promise to help clinicians detect cancer and assess cancer stage in the future. Unlike many blood-based tests for cancer, which detect genetic material from tumours, this test uses a technique called NMR metabolomics, which uses high magnetic fields and radio waves to profile levels of natural chemicals (metabolites) in the blood.
Healthy individuals, people with localised cancer, and people with metastatic cancer each have different profiles of blood metabolites, which can be detected and then analysed by the researchers’ algorithms to distinguish between these states.
Dr James Larkin, researcher on the study from the University of Oxford, says: ‘Cancer cells have unique metabolomic fingerprints due to their different metabolic processes. We are only now starting to understand how metabolites produced by tumours can be used as biomarkers to accurately detect cancer. We have already demonstrated that this technology can successfully identify if patients with multiple sclerosis are progressing to the later stages of disease, even before trained clinicians could tell. It is very exciting that the same technology is now showing promise in other diseases, like cancer.’
Cancers detected earlier are more likely to be treated successfully. This rapid and inexpensive test could help to overcome many barriers to the early detection of cancer, especially in patients that present with non-specific symptoms, which do not direct investigations towards a specific organ. NHS Rapid Diagnostic Centres, similar to Oxfordshire’s SCAN pathway, are currently being set up across the NHS to support faster and earlier cancer diagnosis in all patients with symptoms that could indicate cancer.
This new test is not specific to a single cancer type and has shown promise in this traditionally challenging clinical context, including the potential to detect some cancers in the community before conventional imaging is performed.
Dr Fay Probert, lead researcher of the study from the University of Oxford, says: ‘This work describes a new way of identifying cancer. The goal is to produce a test for cancer that any GP can request. We envisage that metabolomic analysis of the blood will allow accurate, timely and cost-effective triaging of patients with suspected cancer, and could allow better prioritisation of patients based on the additional early information this test provides on their disease.’
Future studies with larger patient cohorts will further evaluate this technique for the earlier detection of new cancers and potential clinical applications.
Original Article: New test can identify if a patient has cancer and if it has spread
More from: University of Oxford
The Latest on: Cancer blood test
- Kirstie Alley died of colon cancer. These are the disease's early signs.on December 6, 2022 at 5:07 pm
Colorectal cancer is the fourth-most common cancer in the U.S. Doctors recommend a colonoscopy every 10 years for people ages 45 and up.
- Kirstie Alley’s ‘recently discovered’ colon cancer battle: What to know about the diseaseon December 6, 2022 at 4:38 pm
Actress Kirstie Alley passed away this week at age 71 after a recent battle with colon cancer, her family said. Here's what people need to know about colon cancer and preventing or detecting it.
- Kirstie Alley died of colon cancer. Here’s how to lower your riskon December 6, 2022 at 2:54 pm
Colorectal cancer, which includes colon and rectal cancers, is the second most deadly cancer today and is striking more younger people in the prime of their lives. Here's how to use screening to lower ...
- Kirstie Alley died from colon cancer, a silent disease that usually doesn’t have symptoms until it’s too late. Here’s what you need to knowon December 6, 2022 at 1:30 pm
Alley had received treatment at Moffitt Cancer Center in Tampa, Florida and her rep later confirmed to People that the 71-year-old actress had died of colon cancer, a disease that saw more than ...
- How genetic testing could help you find breast cancer earlyon December 6, 2022 at 12:00 pm
A blood or saliva sample is used for genetic testing. Doctors are looking for a genetic mutation that increases someone's chances of developing cancer.
- An innovative, noninvasive test could detect cancer in early stageson December 6, 2022 at 8:59 am
In a new study, researchers argue that a noninvasive test checking for tell-tale biomarkers in urine and blood samples could help detect 14 different cancer types in the early stages.
- Colorectal cancer doesn’t wait - DNA methylation tests facilitate earlier treatmenton December 6, 2022 at 8:57 am
In this interview, Yantao Li and Zhe Wang, Director of Cancer Early Screening Products and the Product Director of Oncology at BGI Genomics, talks to NewsMedical about colorectal cancer (CRC), ...
- I Thought It Was Cancer: Mom Who Gave Birth at 49 on Her Miracle Babyon December 6, 2022 at 5:00 am
"I went to the doctor expecting a menopause diagnosis and just two hours later, I was having an emergency ultrasound as they thought it might be cancer." ...
- Toby Keith Shares Stomach Cancer Update: "It's Pretty Debilitating"on December 6, 2022 at 4:00 am
The 61-year-old was diagnosed with stomach cancer in fall 2021, and first revealed what was happening in June 2022.
- Prostate Cancer: How Family History, Gene Variants Raise the Risks for Black Menon December 6, 2022 at 2:20 am
Researchers say gene variants and family history on important factors in prostate cancer risk among Black men. Experts say that's why screenings are vital.
via Bing News
The Latest on: Cancer blood test
[google_news title=”” keyword=”cancer blood test” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
Add Comment